Drug Type Fab fragment, Biosimilar |
Synonyms Ranibizumab Biosimilar (Xbrane Biopharma AB), Xlucane, 雷珠单抗生物类似药(Xbrane Biopharma AB) + [1] |
Target |
Action inhibitors |
Mechanism VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (09 Nov 2022), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Choroidal Neovascularization | European Union | 09 Nov 2022 | |
Choroidal Neovascularization | Iceland | 09 Nov 2022 | |
Choroidal Neovascularization | Liechtenstein | 09 Nov 2022 | |
Choroidal Neovascularization | Norway | 09 Nov 2022 | |
Diabetic macular oedema | European Union | 09 Nov 2022 | |
Diabetic macular oedema | Iceland | 09 Nov 2022 | |
Diabetic macular oedema | Liechtenstein | 09 Nov 2022 | |
Diabetic macular oedema | Norway | 09 Nov 2022 | |
Diabetic Retinopathy | European Union | 09 Nov 2022 | |
Diabetic Retinopathy | Iceland | 09 Nov 2022 | |
Diabetic Retinopathy | Liechtenstein | 09 Nov 2022 | |
Diabetic Retinopathy | Norway | 09 Nov 2022 | |
Retinal vein occlusion-related macular edema | European Union | 09 Nov 2022 | |
Retinal vein occlusion-related macular edema | Iceland | 09 Nov 2022 | |
Retinal vein occlusion-related macular edema | Liechtenstein | 09 Nov 2022 | |
Retinal vein occlusion-related macular edema | Norway | 09 Nov 2022 | |
Wet age-related macular degeneration | European Union | 09 Nov 2022 | |
Wet age-related macular degeneration | Iceland | 09 Nov 2022 | |
Wet age-related macular degeneration | Liechtenstein | 09 Nov 2022 | |
Wet age-related macular degeneration | Norway | 09 Nov 2022 |
Phase 3 | 582 | (Xlucane (Proposed Ranibizumab Biosimilar)) | jilokuinzw(uafmgezvdl) = uhqsrgemyi ngyryvltmb (zjnspleyvq, izxxwcsezv - hwackjogjx) View more | - | 13 Nov 2023 | ||
Lucentis (Ranibizumab) (Lucentis (Ranibizumab)) | jilokuinzw(uafmgezvdl) = wogrzkobyr ngyryvltmb (zjnspleyvq, jpehrgcmuu - whuvaiwdph) View more |